scholarly journals Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Diabetes ◽  
2019 ◽  
Vol 68 (6) ◽  
pp. 1267-1276 ◽  
Author(s):  
Michael J. Haller ◽  
S. Alice Long ◽  
J. Lori Blanchfield ◽  
Desmond A. Schatz ◽  
Jay S. Skyler ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Type 1 Diabetes ◽  
T Cell ◽  
Low Dose ◽  
Clinical Trial Data ◽  
Trial Data ◽  
C Peptide ◽  
Onset Type ◽  
New Onset

scholarly journals Clinical trial data validate the C-peptide estimate model in type 1 diabetes

Diabetologia ◽  
2020 ◽  
Vol 63 (4) ◽  
pp. 885-886
Author(s):  
John M. Wentworth ◽  
Naiara G. Bediaga ◽  
Stephen E. Gitelman ◽  
Carmela Evans-Molina ◽  
Peter A. Gottlieb ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Clinical Trial Data ◽  
Trial Data ◽  
C Peptide

scholarly journals Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes

2018 ◽  
Vol 20 (4) ◽  
pp. 293-307 ◽  
Author(s):  
Peter S. Linsley ◽  
Carla J. Greenbaum ◽  
Mario Rosasco ◽  
Scott Presnell ◽  
Kevan C. Herold ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
T Cell ◽  
Clinical Response ◽  
Peripheral Blood ◽  
Onset Type ◽  
New Onset

scholarly journals Genetic-induced Variations in the GAD65 T-cell Repertoire Governs Efficacy of Anti-CD3/GAD65 Combination Therapy in New-onset Type 1 Diabetes

2010 ◽  
Vol 18 (2) ◽  
pp. 307-316 ◽  
Author(s):  
Damien Bresson ◽  
Matthew Fradkin ◽  
Yulia Manenkova ◽  
Diane Rottembourg ◽  
Matthias von Herrath
Keyword(s):  
Type 1 Diabetes ◽  
T Cell ◽  
Combination Therapy ◽  
T Cell Repertoire ◽  
Cell Repertoire ◽  
Onset Type ◽  
New Onset

F.47. Ingested IFN-alpha2A Prolongs the 'Honeymoon' Phase in New Onset Type 1 Diabetes Mellitus (T1D) in a Phase II Randomized Clinical Trial (RCT)

2009 ◽  
Vol 131 ◽  
pp. S107
Author(s):  
Kristina Rother ◽  
Rebecca Brown ◽  
Elizabeth Wright ◽  
Miriam Morales ◽  
Carol Campbell ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Randomized Clinical Trial ◽  
Phase Ii ◽  
Onset Type ◽  
New Onset

scholarly journals A Reg Family Protein Is Overexpressed in Islets From a Patient With New-Onset Type 1 Diabetes and Acts as T-Cell Autoantigen in NOD Mice

Diabetes ◽  
2002 ◽  
Vol 51 (2) ◽  
pp. 339-346 ◽  
Author(s):  
W. Gurr ◽  
R. Yavari ◽  
L. Wen ◽  
M. Shaw ◽  
C. Mora ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
T Cell ◽  
Nod Mice ◽  
Onset Type ◽  
Family Protein ◽  
New Onset

scholarly journals Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics

2018 ◽  
Vol 19 (5) ◽  
pp. 945-954 ◽  
Author(s):  
Gordon C Weir ◽  
Mario R Ehlers ◽  
Kristina M Harris ◽  
Sai Kanaparthi ◽  
Alice Long ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Open Label ◽  
Onset Type ◽  
Open Label Phase ◽  
Alpha 1 Antitrypsin ◽  
New Onset
Sign in / Sign up

Export Citation Format

Share Document